Cessation

September 18, 2026 The Manager Listing Department, The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai – 400051. Dear Sir/Madam, Trading Symbol: ZOTA Sub: Cessation of Mrs. Varshabahen Gaurang Mehta, Independent Director of the Company upon completion of her tenure Ref.: Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 With reference to the captioned subject; we, Zota Health Care Limited (“the Company”), would like to inform you that the second term of Mrs. Varshabahen Gaurang Mehta (DIN:07611561), as the Independent Director of the Company has been completed on September 09, 2026. Consequently, Mrs. Varshabahen Gaurang Mehta has ceased to be the Independent Director of the Company with effect from September 09, 2026, upon completion of her tenure. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are annexed herewith as Annexure-1. This is for your information and record. Thanking you, Yours faithfully, For Zota Health Care Limited Ashvin Variya (Group Company Secretary & Compliance Officer) Place: Surat Encl.: a/a Registered Office: Zota House, 2/896, Hira Modi Street, Sagrampura, Surat-395002 Ph: +91 261 2331601 Email: info@zotahealthcare.com Web: www.zotahealthcare.com CIN: L24231GJ2000PLC038352 Annexure-1 Particulars Details Name of Director Mrs. Varshabahen Gaurang Mehta (DIN: 07611561) Reason for change viz. appointment, resignation, Cessation of Mrs. Varshabahen Gaurang removal, death or otherwise Mehta as the Independent Director of the Company, upon completion of her tenure. Date of appointment/cessation/reappointment (as September 09, 2026 applicable) & term of appointment Brief profile (in case of appointment) N.A. Disclosure of Relationship between Directors (in case N.A. of appointment of a director) Information as required under applicable SEBI N.A. Circulars